Dielenseger, Pascale
Börjeson, Sussanne
Vidall, Cheryl
Young, Annie
Jahn, Patrick
Article History
Received: 24 September 2018
Accepted: 8 February 2019
First Online: 19 February 2019
Compliance with ethical standards
:
: The authors have the following conflicts of interest to disclose:<i>Dielenseger</i>: Advisory boards: Helsinn, Roche, Shire, Tesaro, BMS, Pfizzer, Janssen Cilag, Bayer Healthcare, IPSEN.<i>Börjeson</i>: None.<i>Vidall</i>: None.<i>Young</i>: Honoraria from Helsinn, Bayer, Leo Pharma; Educational grant from Bayer.<i>Jahn</i>: Travel support: Helsinn (2014); Consulting or Advisory role: Bristol-Myers Squibb, Chugai, Norgine and Clinigen; Clinical Research Fund by Chugai